Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines of therapy, with no new safety signals emerging over time.

EPFL scientists have integrated discarded crustacean shells into robotic devices, leveraging the strength and flexibility of ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement | Akebia Therapeutics has struck a deal for Q32 ...

The mood on the stock market was gloomy on Monday, but apparently somebody forgot to notify Belite Bio ( BLTE +12.06%). The ...

A recent spill of bio-beads—small plastic pellets used by some wastewater treatment facilities since the 1990s—has brought ...

Pivot Bio uses gene editing to turn naturally-occurring nitrogen-fixing soil microbes into microscopic fertilizer production ...

In conjunction with Tract’s move to Connect Labs Charlotte, the company’s scientific co-founders, Frank McKeon, Ph.D., and Wa ...

Lane Kiffin completed the "highly requested" change of his social media bio Tuesday to reflect his new position as the head ...

The average one-year price target for Korro Bio (NasdaqCM:KRRO) has been revised to $45.90 / share. This is a decrease of ...

The average one-year price target for Upstream Bio (NasdaqGS:UPB) has been revised to $51.00 / share. This is a decrease of ...